Patents by Inventor Asad Shah

Asad Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DETERMINATION OF ANTIDEPRESSANTS BY MASS SPECTROMETRY
    Publication number: 20240120188
    Abstract: A method for detecting or determining an amount of one or more serotonin and norepinephrine reuptake inhibitors (SNRI) and SNRI metabolites in a sample by tandem mass spectrometry includes subjecting the sample to ionization under conditions suitable to produce one or more ions detectable by mass spectrometry; determining the amount of one or more ions by tandem mass spectrometry; and determining the amount of SNRI and SNRI metabolites in the sample based upon the amount of the one or more ions determined by tandem mass spectrometry; and wherein the one or more SNRI and SNRI metabolites includes duloxetine.
    Type: Application
    Filed: December 18, 2023
    Publication date: April 11, 2024
    Inventors: Anita Dermartirosian, Edith Shahbol, Karin Thomassian, Shaun Rezaei, Asad Shah
  • Determination of antidepressants by mass spectrometry
    Patent number: 11887828
    Abstract: Methods are described for detecting or determining the amount of antidepressants and/or antidepressant metabolites in a sample. More specifically, mass spectrometric methods are described for detecting and quantifying antidepressants and/or antidepressant metabolites in a sample.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: January 30, 2024
    Assignee: Quest Diagnostics Investments LLC
    Inventors: Anita Dermartirosian, Edith Shahbol, Karin Thomassian, Shaun Rezaei, Asad Shah
  • Determination of Antidepressants by Mass Spectrometry
    Publication number: 20200381228
    Abstract: Methods are described for detecting or determining the amount of antidepressants and/or antidepressant metabolites in a sample. More specifically, mass spectrometric methods are described for detecting and quantifying antidepressants and/or antidepressant metabolites in a sample.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 3, 2020
    Applicant: Quest Diagnostics Investments LLC
    Inventors: Anita Dermartirosian, Edith Shahbol, Karin Thomassian, Shaun Rezaei, Asad Shah